Φορτώνει......
iRECIST: how to do it
BACKGROUND: iRECIST for the objective monitoring of immunotherapies was published by the official RECIST working group in 2017. MAIN BODY: Immune-checkpoint inhibitors represent one of the most important therapy advancements in modern oncology. They are currently used for treatment of multiple malig...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Cancer Imaging |
|---|---|
| Κύριοι συγγραφείς: | , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
BioMed Central
2020
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6942293/ https://ncbi.nlm.nih.gov/pubmed/31900236 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40644-019-0281-x |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|